Sjögren's
Sjögren's
Discover, Learn, and Thrive with Health Study
What is Sjögren's Study
The study is for participants with moderate to severe Sjogren’s to take a medicine to evaluate the effect on symptoms with the goal of relieving dryness and to reduce tender and swollen joints.
Inclusion criteria includes adults over 18 years of age with diagnosis of Sjogren’s. Must be vaccinated against Covid 19 and be negative for Tuberculosis.
Exclusion Criteria includes history of deep vein thrombosis. Polymyositis, systemic sclerosis or dermatomyositis. If you are pregnant or lactating, have a history of Hepatitis B or C, have had previous treatment with biologic B Cell depleting therapy within the last 12 months or are on antimalarials, methotrexate, azathioprine, DMARD’s, immunosuppressant or antiproliferative agents, this study may not work for you.
Discover New Horizons of Health with Bradenton Research – Your Journey to Optimal Wellness!"
Benefits of Sjögren's Syndrome Study
- Here are some of the benefits:
- Advances understanding and treatment of Sjögren's syndrome.
- Access to innovative therapies and interventions.
- Comprehensive medical monitoring and specialized care.
- Contribution to scientific knowledge and future advancements.
- Supportive community engagement and resources.
Bradenton Research Center: Meeting Tomorrow’s Medical Care
We support safe and effective health and patient care. Whether you’re a patient, a provider, a participant, or a medical researcher, we work day and night to offer solutions to all of your health-related concerns. Think of us as your number-one source of reliable health and medical expertise. Contact us today!